FDA Probes Dialysis Company Over Failure to Warn of Product Risk
The U.S. Food and Drug Administration is probing Fresenius Medical Care – the nation’s largest operator of dialysis centers – to determine if it violated federal regulations by not informing the public of a possibly deadly risk linked to one of its products. In November 2011, Fresenius sent an internal memo to doctors practicing in the company’s dialysis centers, warning them that improper use of its GranuFlo